CNBX Pharmaceuticals Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $15.1K | $26.4K | $129.7K | $117.5K | $1.4M | $777.6K | $266.0K | $1.4M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $18.4K | $31.4K | $224.3K | $198.3K | $1.6M | $929.9K | $4.3M | $1.6M |
| Property, Plant & Equipment | $0 | $0 | $274.7K | $436.8K | $642.9K | $862.9K | $1.0M | $974.3K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $18.4K | $31.4K | $499.0K | $811.2K | $3.1M | $2.2M | $15.2M | $3.2M |
| Liabilities | ||||||||
| Accounts Payable | $49.3K | $40.8K | $335.9K | $461.1K | $177.5K | $231.1K | $215.2K | $315.7K |
| Total Current Liabilities | $2.5M | $2.5M | $2.5M | $2.4M | $1.3M | $454.8K | $438.9K | $539.4K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $2.5M | $2.5M | $2.5M | $-821.1K | $1.3M | $454.8K | $438.9K | $539.4K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-25.3M | $-25.0M | $-24.3M | $-20.5M | $-16.8M | $-13.6M | $-6.2M | $-7.3M |
| Total Stockholders' Equity | $-2.5M | $-2.5M | $-2.0M | $1.6M | $1.8M | $1.8M | $14.7M | $2.6M |